A robot named Adam was the first of its kind to do science. Adam mimicked a biologist. After coming up with questions to ask about yeast, the machine tested those questions inside a robotic laboratory ...

In the rapidly evolving world of biotechnology and pharmaceuticals, innovation is the key to staying ahead. One of the most groundbreaking developments in recent years is the alliance between BenchSci ...

AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.

The field of microbial enzyme research is rapidly evolving as biotechnology and industrial processes increasingly depend on the exploitation of microbial ...

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

An independent digital publication launches with coverage of AI trust, data governance, and emerging technologies, open ...

ARTIFICIAL intelligence is no longer just a peripheral tool in research. The rapid accumulation, availability and accessibility of data sets has now become a structural layer of the scientific method ...